MediaAlpha, Inc. (MAX)
NYSE: MAX · Real-Time Price · USD
9.93
-1.02 (-9.36%)
Aug 11, 2025, 11:02 AM - Market open
Oncternal Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2020 |
| 1,076 | 864.7 | 388.15 | 459.07 | 645.27 | 584.81 | Upgrade | |
Revenue Growth (YoY) | 116.59% | 122.78% | -15.45% | -28.86% | 10.34% | 43.34% | Upgrade |
Cost of Revenue | 908.18 | 721.13 | 321.44 | 389.01 | 543.75 | 499.43 | Upgrade |
Gross Profit | 167.53 | 143.57 | 66.71 | 70.06 | 101.52 | 85.38 | Upgrade |
Selling, General & Admin | 68.15 | 69.99 | 83.88 | 84.37 | 84.18 | 53.4 | Upgrade |
Research & Development | 20.59 | 19.76 | 18.46 | 21.08 | 15.2 | 12.45 | Upgrade |
Operating Expenses | 88.74 | 89.76 | 102.33 | 105.45 | 99.38 | 65.85 | Upgrade |
Operating Income | 78.8 | 53.82 | -35.62 | -35.39 | 2.15 | 19.54 | Upgrade |
Interest Expense | -12.58 | -14.35 | -15.32 | -9.25 | -7.83 | -7.94 | Upgrade |
Other Non Operating Income (Expenses) | 3.19 | 2.13 | -0.37 | 75.09 | -3.84 | -2.3 | Upgrade |
EBT Excluding Unusual Items | 69.41 | 41.6 | -51.3 | 30.46 | -9.52 | 9.3 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | -1.41 | - | - | - | Upgrade |
Legal Settlements | -51.45 | -11.09 | -4.3 | - | - | - | Upgrade |
Other Unusual Items | -8.73 | -7.01 | -0.01 | - | - | - | Upgrade |
Pretax Income | -4.18 | 23.5 | -57.02 | 30.46 | -9.52 | 9.3 | Upgrade |
Income Tax Expense | 1.49 | 1.38 | -0.46 | 102.91 | -1.05 | -1.27 | Upgrade |
Earnings From Continuing Operations | -5.68 | 22.12 | -56.56 | -72.45 | -8.48 | 10.56 | Upgrade |
Minority Interest in Earnings | -0.89 | -5.49 | 16.14 | 14.78 | 3.2 | 4.24 | Upgrade |
Net Income | -6.57 | 16.63 | -40.42 | -57.67 | -5.28 | 14.8 | Upgrade |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 19.17 | Upgrade |
Net Income to Common | -6.57 | 16.63 | -40.42 | -57.67 | -5.28 | -4.37 | Upgrade |
Net Income Growth | - | - | - | - | - | -16.95% | Upgrade |
Shares Outstanding (Basic) | 56 | 53 | 46 | 42 | 37 | 32 | Upgrade |
Shares Outstanding (Diluted) | 56 | 53 | 46 | 42 | 61 | 32 | Upgrade |
Shares Change (YoY) | 13.73% | 16.39% | 8.65% | -31.52% | 90.63% | 3061.47% | Upgrade |
EPS (Basic) | -0.12 | 0.31 | -0.89 | -1.37 | -0.14 | -0.14 | Upgrade |
EPS (Diluted) | -0.12 | 0.31 | -0.89 | -1.37 | -0.19 | -0.14 | Upgrade |
Free Cash Flow | 71.69 | 45.62 | 20.16 | 28.18 | 27.97 | 51.11 | Upgrade |
Free Cash Flow Per Share | 1.29 | 0.86 | 0.44 | 0.67 | 0.46 | 1.59 | Upgrade |
Gross Margin | 15.57% | 16.60% | 17.19% | 15.26% | 15.73% | 14.60% | Upgrade |
Operating Margin | 7.32% | 6.22% | -9.18% | -7.71% | 0.33% | 3.34% | Upgrade |
Profit Margin | -0.61% | 1.92% | -10.41% | -12.56% | -0.82% | -0.75% | Upgrade |
Free Cash Flow Margin | 6.66% | 5.28% | 5.19% | 6.14% | 4.33% | 8.74% | Upgrade |
EBITDA | 84.22 | 60.5 | -28.35 | -29.24 | 5.5 | 23.03 | Upgrade |
EBITDA Margin | 7.83% | 7.00% | -7.30% | -6.37% | 0.85% | 3.94% | Upgrade |
D&A For EBITDA | 5.42 | 6.68 | 7.27 | 6.15 | 3.35 | 3.49 | Upgrade |
EBIT | 78.8 | 53.82 | -35.62 | -35.39 | 2.15 | 19.54 | Upgrade |
EBIT Margin | 7.32% | 6.22% | -9.18% | -7.71% | 0.33% | 3.34% | Upgrade |
Effective Tax Rate | - | 5.89% | - | 337.85% | - | - | Upgrade |
Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.